|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_1859 | ED148172 | General Research Use | No | Female | White | 77 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_2262 | ED148849 | General Research Use | No | Female | White | 74 | 9 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_2396 | ED149151 | General Research Use | No | Female | White | 67 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3456 | ED148630 | General Research Use | No | Male | White | 72 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_1659 | ED148360 | General Research Use | No | Female | White | 82 | 9 - AREDS AMD Severity Scale Step 9 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2086 | ED148661 | General Research Use | No | Male | White | 76 | 9 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2596 | ED148271 | General Research Use | No | Male | White | 62 | 9 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2690 | ED148541 | General Research Use | No | Female | White | 65 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_3026 | ED149078 | General Research Use | No | Male | White | 56 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_3750 | ED149952 | General Research Use | No | Female | White | 62 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0309 | ED148361 | General Research Use | No | Female | White | 79 | 9 - AREDS AMD Severity Scale Step 9 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_0638 | ED149307 | General Research Use | No | Female | White | 78 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0990 | ED148895 | General Research Use | No | Male | White | 62 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_2148 | ED148310 | General Research Use | No | Female | White | 81 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2243 | ED149450 | General Research Use | No | Male | White | 64 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_2353 | ED148320 | General Research Use | No | Male | White | 83 | 9 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2500 | ED149855 | General Research Use | No | Female | White | 72 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3243 | ED148206 | General Research Use | No | Male | White | 63 | 9 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0510 | ED148369 | General Research Use | No | Female | White | 76 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0738 | ED149645 | General Research Use | No | Female | White | 67 | 9 - AREDS AMD Severity Scale Step 4 | 9 - AREDS AMD Severity Scale Step 9 |